Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Network-based drug repurposing for schizophrenia
    Published on 2024-02-05
    2 years ago
  • Identifying novel proteins for suicide attempt by integrating proteomes from brain and blood with genome-wide association data
    Published on 2024-02-04
    2 years ago
  • Heartbeat-evoked neural response abnormalities in generalized anxiety disorder during peripheral adrenergic stimulation
    Published on 2024-01-29
    2 years ago
  • Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
    Published on 2024-01-28
    2 years ago
  • Data-driven connectivity profiles relate to smoking cessation outcomes
    Published on 2024-01-26
    3 years ago
  • Reproducible stability of verbal and spatial functions along the menstrual cycle
    Published on 2024-01-23
    3 years ago
  • Retraction Note: Predator odor increases avoidance and glutamatergic synaptic transmission in the prelimbic cortex via corticotropin-releasing factor receptor 1 signaling
    Published on 2024-01-21
    3 years ago
« Previous 1 … 99 100 101 102 103 … 143 Next »
Journal of Psychopharmacology
  • Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age
    Published on 2021-03-29
    5 years ago
  • Effects of hydrocortisone and yohimbine on selective attention to emotional cues
    Published on 2021-03-29
    5 years ago
  • Cannabis-induced oceanic boundlessness
    Published on 2021-03-29
    5 years ago
  • Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview
    Published on 2021-03-29
    5 years ago
  • Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice
    Published on 2021-03-26
    5 years ago
  • Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice
    Published on 2021-03-22
    5 years ago
  • Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action
    Published on 2021-03-20
    5 years ago
« Previous 1 … 99 100 101 102 103 … 150 Next »
European Neuropsychopharmacology
  • Well-Being, Resilience and Post-traumatic growth in the Era of Covid-19 Pandemic
    Published on 2021-09-03
    5 years ago
  • Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up
    Published on 2021-09-02
    5 years ago
  • Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder
    Published on 2021-08-28
    5 years ago
  • The impact of the Covid-19 pandemic on patients with schizophrenia
    Published on 2021-08-14
    5 years ago
  • Drugs do not work if patients do not take them
    Published on 2021-08-14
    5 years ago
  • No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
    Published on 2021-08-08
    5 years ago
  • The effect of intranasally administered oxytocin on observed social behavior in social anxiety disorder
    Published on 2021-08-04
    5 years ago
« Previous 1 … 99 100 101 102 103 … 168 Next »

   Pharma Pub